New RAPEX Guidelines Published as Implementing Decision 2019/417

Even commercial products can now be reported

As reported in our 01/2019 issue, the Commission adopted the new RAPEX guidelines on 8 November 2018. These have now been published as Implementing Decision (EU) 2019/417 on 15 March 2019 in Official Journal L 73. This implementing decision replaces Decision 2010/15/EU with effect from 15 March 2019.

The special feature is that, in accordance with Article 22 of Regulation (EC) 765/2008, all product areas of this Regulation - including commercial products, e.g. in accordance with the Low Voltage, EMC, Radio Equipment or Machinery Directives - are now covered.

Only the following products are excluded from this: Food, feed and other products in accordance with Regulation (EC) No. 178/2002, medicinal products in accordance with Directive 2001/83/EC and Directive 2001/82/EC, medical products in accordance with Regulation (EU) 2017/745 and active implantable medical devices in accordance with Directive 90/385/EEC.

GLOBALNORM ACADEMY will develop an appropriate training program for this purpose.

Compliance News

The latest developments in all areas of market authorization and product compliance.

Mehr Know-how und Service zu Product Compliance

In accordance with the EU ePrivacy (Cookie) Directive (2009/136/EG), we would like to inform you that our website uses cookies. By using our website, you accept and agree to our Privacy policy. Please view our Privacy policy to find out what cookies we use and how to disable them.